Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,973.00
Bid: 1,971.00
Ask: 1,972.00
Change: 17.00 (0.87%)
Spread: 1.00 (0.051%)
Open: 1,963.00
High: 1,994.00
Low: 1,959.00
Prev. Close: 1,956.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: RBS Misses Gains After Swinging To Operating Loss

Fri, 05th Aug 2016 07:33

LONDON (Alliance News) - Stocks in London were higher Friday morning, with investors still celebrating the Bank of England's easing measures, but Royal Bank of Scotland Group shares were missing out after it said it swung to an operating loss in the first half of 2016.

The FTSE 100 index was up 0.6%, or 39.44 points, at 6,779.60. The FTSE 250 was up 0.3% at 17,293.09 and the AIM-All Share up 0.3% at 764.17.

RBS shares were down 5.2%, the worst performer in the FTSE 100. The lender, which is 73%-owned by the UK government, said it made an operating loss of GBP274.0 million in the half to the end of June, swung from a GBP261.0 million profit a year prior.

RBS's loss for the half, attributable to ordinary shareholders after its final dividend access payment, was GBP2.05 billion, compared to a GBP179.0 million loss a year before. This includes the dividend access payment, which amounted to GBP1.19 billion, plus GBP1.31 billion in litigation and conduct costs.

RBS said its adjusted operating profit for the half, which removes one-off costs along with litigation and conduct charges, was GBP1.16 billion, down from GBP2.89 billion a year before. Adjusted operating profit for the bank's Personal & Business Banking, Commercial & Private Banking and Corporate & Institutional Banking franchises fell 15% in the half and the profit was further hit by increased volatility losses.

RBS said its common equity tier 1 ratio was 14.5% at the end of June, still ahead of its 13.0% target. The CET1 ratio is a key measure of bank profitability and the ability of the lender to pay dividends.

At the top end of the large-cap index was Hikma Pharmaceuticals, up 2.8%, recovering some of the ground lost Thursday, when it fell 17%. The drug company late Wednesday said it expects full-year operating profit within its Generics division to be hit by changes in revenue mix, but maintained its guidance on its other two divisions.

In the FTSE 250, Ibstock was up 7.1%, the biggest mid-cap gainer. The clay bricks manufacturer said it has contingency plans in place to enable it to balance production with sales volumes for the remainder of the year as a response to the uncertainty resulting from the UK's vote to leave the European Union.

The building materials company said its key focus under these plans will be the management of stock levels and said capacity will be flexed to balance production with sales levels as necessary. Ibstock said it will manage its cost base in response to the evolution of its markets as visibility improves.

The comments came as Ibstock posted revenue for the six months ended June 30 of GBP210.0 million, up from GBP148.9 million a year earlier. Pretax profit came in at GBP37.9 million from GBP77.0 million a year earlier, including GBP51.8 million in net exceptional benefits a year earlier which did not repeat. Ibstock declared an interim dividend of 2.4 pence per share, having offered no interim dividend a year earlier.

Shares in Esure Group were down 4.7%. The insurer trimmed its interim dividend to 3.0 pence from 4.2p a year earlier and below the 3.5p forecast by DividendMax. Esure said it was cutting the dividend in order to fund growth across its divisions.

Pretax profit for the half-year to the end of June was GBP30.7 million, down 69% from GBP97.6 million a year earlier. The 2015 half-year pretax profit had been flattered by a one-off gain booked on the value of esure's holding in GoCompare. Underlying pretax profit, taking out the one-off effects, was essentially flat in the first half, at GBP45.6 million versus GBP46.5 million a year prior.

In mainland Europe, the CAC 40 index in Paris was 0.7% and the DAX 30 in Frankfurt was 0.2%.

In Asia on Friday, the Japanese Nikkei 225 index ended flat. The Chinese Shanghai Composite dropped 0.2%, while the Hang Seng index in Hong Kong continues up 1.4%.

On Thursday, the BoE's Monetary Policy Committee voted unanimously to cut UK interest rates by 25 basis points to 0.25%.

In addition, the BOE expanded the size of its asset purchase facility programme, with the increase totalling GBP170 billion as a whole. It included the expansion of UK government bonds purchases by GBP60 billion to GBP435 billion, up to GBP10 billion in UK corporate bonds and introduced a Term Funding Scheme, worth "around GBP100 billion", aimed to help reinforce the transmission of the interest rate cut to the real economy.

The highlight in the economic calendar Friday is US nornfarm payrolls, scheduled at 1330 BST. US payrolls are expected to come in at 180,000, down from the 287,000 seen in June, according to FXStreet.com.

Average hourly earnings are expected to grow 0.2% on a monthly basis, compared to a 0.1% rise in June, and 2.6% year-on-year, flat against the June reading. The US unemployment rate is expected to show a fall to 4.8%, compared to the 4.9% seen in June.

Elsewhere, there are UK Halifax house prices at 0830 BST and the US Baker Hughes US oil rig count at 1800 BST.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more
3 Nov 2022 11:08

With tighter purse strings, is parity less probable for the pound?

STOXX 600 down 1.1%

*

Read more
3 Nov 2022 09:28

Banks, insurance dodge carnage as real estate stocks sink

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.